LivaNova PLC (LIVN) Financial Statements
Industry: Electromedical & Electrotherapeutic Apparatus
In fiscal 2025, LivaNova reported revenue of $1.39B, up 10.7% from $1.25B the year before. Net income was -$242.5M (a -17.5% net margin), or -$4.45 per diluted share. Gross margin was 67.7% and operating margin was 14.4%. Operating activities generated $254.3M of cash, leaving $173.3M of free cash flow. At fiscal year end, LivaNova held $2.61B in total assets against $1.41B in total liabilities, including $635.6M of cash and equivalents.
Open the full interactive LivaNova financials → Quarterly statements, key ratios, valuation history and price charts.
LivaNova Key Stats
| Share Price | $76.37 |
|---|---|
| Market Cap | $4.30B |
| Revenue YoY Growth | +10.7% |
| 52-Week Range | $49.57 – $85.32 |
| Shares Outstanding | 55.0 million (basic, 2026 Q2) |
LivaNova Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $934.2M | $1.04B | $1.02B | $1.15B | $1.25B | $1.39B |
| Cost of Goods Sold | $308.1M | $329.4M | $314.6M | $382.3M | $382.6M | $448.2M |
| Gross Profit | $626.2M | $706.0M | $707.2M | $771.2M | $870.9M | $939.9M |
| Operating Income | -$269.9M | -$784,000 | -$76.8M | -$68.5M | $129.1M | $199.4M |
| Pre-Tax Income | -$344.0M | -$124.5M | -$75.1M | -$81.2M | $88.3M | -$220.8M |
| Income Tax | -$736,000 | $11.2M | $11.1M | -$98.9M | $25.1M | $21.6M |
| Net Income | -$345.0M | -$135.8M | -$86.2M | $17.5M | $63.2M | -$242.5M |
| Diluted EPS | -$7.10 | -$2.68 | -$1.61 | $0.32 | $1.16 | -$4.45 |
LivaNova Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $357.8M | $360.9M | $362.3M | $390.6M |
| Net Income | $26.8M | $30.9M | $22.3M | $108.6M |
| Diluted EPS | $0.49 | $0.57 | $0.40 | $1.93 |
LivaNova Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $252.8M | $208.0M | $214.2M | $266.5M | $428.9M | $635.6M |
| Current Assets | $719.4M | $679.2M | $886.1M | $988.2M | $1.13B | $1.10B |
| Total Assets | $2.41B | $2.20B | $2.29B | $2.43B | $2.51B | $2.61B |
| Current Liabilities | $309.1M | $697.0M | $297.4M | $335.0M | $392.1M | $808.1M |
| Total Long-Term Debt | $650.7M | $236.8M | $539.0M | $586.0M | $627.0M | $376.1M |
| Total Liabilities | $1.29B | $906.3M | $1.09B | $1.15B | $1.19B | $1.41B |
| Shareholders' Equity | $1.12B | $1.29B | $1.21B | $1.28B | $1.32B | $1.20B |
LivaNova Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$79.4M | $102.5M | $69.9M | $74.9M | $183.0M | $254.3M |
| Cash From Investing | -$41.8M | $36.9M | -$38.4M | -$40.3M | -$48.2M | -$72.9M |
| Cash From Financing | $310.8M | -$181.5M | $280.1M | $21.5M | $18.6M | -$285.7M |
| Free Cash Flow | -$114.4M | $77.1M | $43.4M | $39.9M | $135.9M | $173.3M |
Figures from LivaNova's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full LivaNova financials page for every line item.
LivaNova Company Profile
| Ticker | LIVN |
|---|---|
| Exchange | Nasdaq |
| Industry | Electromedical & Electrotherapeutic Apparatus |
| Headquarters | Gloucester |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001639691 |
Frequently Asked Questions
What was LivaNova's revenue in fiscal 2025?
LivaNova (LIVN) reported revenue of $1.39B for fiscal 2025.
What is LivaNova's annual revenue history?
LivaNova's annual revenue by fiscal year: 2020: $934.2M; 2021: $1.04B; 2022: $1.02B; 2023: $1.15B; 2024: $1.25B; 2025: $1.39B.
What was LivaNova's net income in fiscal 2025?
LivaNova reported net income of -$242.5M for fiscal 2025.
What was LivaNova's earnings per share (EPS) in fiscal 2025?
LivaNova's diluted EPS was -$4.45 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did LivaNova generate in fiscal 2025?
LivaNova generated $173.3M of free cash flow in fiscal 2025.
What was LivaNova's revenue last quarter?
In its most recent reported quarter (2026 Q2), LivaNova reported revenue of $390.6M.
How much debt does LivaNova have?
LivaNova reported $376.1M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of LivaNova are outstanding?
LivaNova reported a weighted average of 55.0 million basic shares outstanding in 2026 Q2.
What is LivaNova's market cap?
Based on its latest closing price, LivaNova (LIVN) has a market capitalization of about $4.30B.
When does LivaNova's fiscal year end?
LivaNova's fiscal year end, as registered with the SEC, is December 31.
Where is LivaNova headquartered?
LivaNova lists its business address in Gloucester in its SEC filings.